Jul 14, 2010
By:
Oriana Schwindt
John Castellani received the nod from PhRMA on Tuesday to take over the role of president and CEO in September.
|
Jul 8, 2010
By:
Oriana Schwindt
With a long, hard fight looming, President Obama decided to go around Congress to install Don Berwick, founder of the Institute for Healthcare Improvement, as the top administrator of the Centers for Medicaid and Medicare Services.
|
|
Jul 1, 2010
By:
Oriana Schwindt
Pharma companies are starting to get back in the game with increased advertising spend in 2009. Do we have economic recovery to thank, or is there a deeper cause?
|
Apr 28, 2010
By:
Oriana Schwindt
A new Cegedim Dendrite study shows just how ill-equipped pharmaceutical companies are to deal with spending disclosure legislation, and how many are turning to third parties to do the job.
|
|
Apr 27, 2010
By:
Oriana Schwindt
As head of GSK's North American pharma, Deirdre Connelly has the daunting challenge of trying to turn around the sluggish US market. If she succeeds, Connelly may find herself auditioning as the first female Big Pharma CEO.
|
Apr 14, 2010
By:
Oriana Schwindt
Lilly's aggressive approach to shrinking the racial gap in drug trials might indicate big changes for the drugmaking process.
|
Mar 31, 2010
By:
Oriana Schwindt
Glaxo and Isis formed a billion-dollar alliance to create new RNA therapies for the rare and infectious disease segment. The key ingredient in the deal is Isis' drug discovery platform. Could it be a game changer? GSK thinks so.
|
Mar 3, 2010
By:
Oriana Schwindt
The Japan-based company filed a lawsuit against OSI Pharmaceuticals for rejecting its tender offer, but will this strategy work?
|
Mar 3, 2010
By:
Oriana Schwindt
Three ad agencies came up with two similarly designed ways of keeping track of online healthcare conversation, harnessing the power of social media sites like Twitter and Digg.
|
|
PharmExec Blog
Follow Us
RSS
Bookstore
